Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Assembly Biosciences Inc (NASDAQ:ASMB)

32.55
Delayed Data
As of Sep 22
 +0.42 / +1.31%
Today’s Change
6.74
Today|||52-Week Range
32.92
+167.90%
Year-to-Date
New Strong Sell Stocks for September 18th
Sep 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close32.13
Today’s open32.05
Day’s range31.90 - 32.92
Volume51,332
Average volume (3 months)95,908
Market cap$565.2M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-41.99%
Earnings growth (this year)-32.30%
Earnings growth (next 5 years)-15.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.03

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...+0.05+0.23%
PGNXProgenics Pharmaceut...0.000.00%
CARACara Therapeutics In...-0.12-0.91%
KPTIKaryopharm Therapeut...+0.15+1.43%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$0.00
Annual profit (last year)-$44.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Derek A. Small
CFO, COO &
Principal Accounting Officer
David J. Barrett
Corporate headquarters
Carmel, Indiana

Forecasts